Intrinsic Value

The intrinsic value of Ypsomed Holding AG (0QLQ) under the Base Case is CHF per share. Compared with the current market price of 436.7 CHF, the stock appears .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

0QLQ Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when 0QLQ is below its intrinsic value
Today Hidden ·
0QLQ Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to 0QLQ

Fundamental Analysis

What Ypsomed Does

Health Care

Ypsomed Holding AG makes drug delivery devices that help patients inject medicines at home. Its core products include insulin pens, pen needles, autoinjectors, and pump systems for people who need regular injections, especially diabetes patients and other chronic-care users. The company also develops and sells connected devices and digital tools that help patients track treatment and use their medicines correctly.

Headquarters
Switzerland CH
Employees
2 025
IPO date
Sep 22, 2004
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q2 fiscal 2027 · November 11, 2026

After a strong first half, Ypsomed raised its full-year outlook for Delivery Systems sales growth and EBIT.

Open the earnings call
Stock, next trading day
+5.6%
View Earnings Call

Past 12 months

Continue 0QLQ Research

Decided on Ypsomed Holding? Get an email when 0QLQ reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one 0QLQ stock?

The intrinsic value for Ypsomed Holding AG (0QLQ) under the Base Case is CHF.

Is 0QLQ stock undervalued or overvalued?

Compared with the current market price of 436.7 CHF, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top